Lyme disease vaccine in late-stage trials would be first in 20 years

Image: Deer tick – Ixodes scapularis. Image credit: US federal government Center for Disease Control (CDC) – Public Domain. Article by Andrew Jeong. The Washington Post – August 9, 2022.

Pfizer and French pharmaceutical company Valneva are enlisting 6,000 people for a late-stage clinical trial that will test a vaccine designed to protect against the tick-borne Lyme disease, the drugmakers said Monday. If development of the vaccine is successful, it could become the first federally approved inoculation against Lyme […]

Click here to view original web page at www.washingtonpost.com